Boryung Corporation (KRX:003850)

Market Cap	871.54B
Revenue (ttm)	991.43B
Net Income (ttm)	62.00B
Shares Out	83.96M
EPS (ttm)	939.14
PE Ratio	11.05
Forward PE	15.29
Dividend	100.00 (0.96%)
Ex-Dividend Date	Dec 27, 2024

Volume	40,150
Average Volume	120,535
Open	10,330
Previous Close	10,330
Day's Range	10,290 - 10,410
52-Week Range	9,180 - 13,750
Beta	0.57
RSI	53.18
Earnings Date	Jan 27, 2025

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 1,533
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003850

Financial Performance

In 2023, Boryung's revenue was 859.63 billion, an increase of 13.04% compared to the previous year's 760.48 billion. Earnings were 40.20 billion, a decrease of -4.04%.